65 related articles for article (PubMed ID: 38633426)
1. Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer.
Zelli V; Compagnoni C; Cannita K; Capelli R; Capalbo C; Di Vito Nolfi M; Alesse E; Zazzeroni F; Tessitore A
High Throughput; 2020 Jan; 9(1):. PubMed ID: 31936873
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology.
Bartha Á; Győrffy B
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31690036
[TBL] [Abstract][Full Text] [Related]
3. A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients.
Bianchi A; Zelli V; D'Angelo A; Di Matteo A; Scoccia G; Cannita K; Dimas AS; Glentis S; Zazzeroni F; Alesse E; Di Marco A; Tessitore A
NAR Genom Bioinform; 2024 Jun; 6(2):lqae033. PubMed ID: 38633426
[TBL] [Abstract][Full Text] [Related]
4. Detection of Disease-Causing SNVs/Indels and CNVs in Single Test Based on Whole Exome Sequencing: A Retrospective Case Study in Epileptic Encephalopathies.
Sun D; Liu Y; Cai W; Ma J; Ni K; Chen M; Wang C; Liu Y; Zhu Y; Liu Z; Zhu F
Front Pediatr; 2021; 9():635703. PubMed ID: 34055682
[No Abstract] [Full Text] [Related]
5. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
[TBL] [Abstract][Full Text] [Related]
7. A practical method to detect SNVs and indels from whole genome and exome sequencing data.
Shigemizu D; Fujimoto A; Akiyama S; Abe T; Nakano K; Boroevich KA; Yamamoto Y; Furuta M; Kubo M; Nakagawa H; Tsunoda T
Sci Rep; 2013; 3():2161. PubMed ID: 23831772
[TBL] [Abstract][Full Text] [Related]
8. Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.
Kang HP; Maguire JR; Chu CS; Haque IS; Lai H; Mar-Heyming R; Ready K; Vysotskaia VS; Evans EA
PeerJ; 2016; 4():e2162. PubMed ID: 27375968
[TBL] [Abstract][Full Text] [Related]
9. ECOLE: Learning to call copy number variants on whole exome sequencing data.
Mandiracioglu B; Ozden F; Kaynar G; Yilmaz MA; Alkan C; Cicek AE
Nat Commun; 2024 Jan; 15(1):132. PubMed ID: 38167256
[TBL] [Abstract][Full Text] [Related]
10. Performance analysis of conventional and AI-based variant callers using short and long reads.
Abdelwahab O; Belzile F; Torkamaneh D
BMC Bioinformatics; 2023 Dec; 24(1):472. PubMed ID: 38097928
[TBL] [Abstract][Full Text] [Related]
11. Truvari: refined structural variant comparison preserves allelic diversity.
English AC; Menon VK; Gibbs RA; Metcalf GA; Sedlazeck FJ
Genome Biol; 2022 Dec; 23(1):271. PubMed ID: 36575487
[TBL] [Abstract][Full Text] [Related]
12. The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of Cancer.
Achilla C; Papavramidis T; Angelis L; Chatzikyriakidou A
Anticancer Res; 2022 May; 42(5):2261-2276. PubMed ID: 35489753
[TBL] [Abstract][Full Text] [Related]
13. Benchmarking germline CNV calling tools from exome sequencing data.
Gordeeva V; Sharova E; Babalyan K; Sultanov R; Govorun VM; Arapidi G
Sci Rep; 2021 Jul; 11(1):14416. PubMed ID: 34257369
[TBL] [Abstract][Full Text] [Related]
14. Sanger sequencing is no longer always necessary based on a single-center validation of 1109 NGS variants in 825 clinical exomes.
Arteche-López A; Ávila-Fernández A; Romero R; Riveiro-Álvarez R; López-Martínez MA; Giménez-Pardo A; Vélez-Monsalve C; Gallego-Merlo J; García-Vara I; Almoguera B; Bustamante-Aragonés A; Blanco-Kelly F; Tahsin-Swafiri S; Rodríguez-Pinilla E; Minguez P; Lorda I; Trujillo-Tiebas MJ; Ayuso C
Sci Rep; 2021 Mar; 11(1):5697. PubMed ID: 33707547
[TBL] [Abstract][Full Text] [Related]
15. Whole Genome Sequencing Prioritizes
Srivastava A; Giangiobbe S; Skopelitou D; Miao B; Paramasivam N; Diquigiovanni C; Bonora E; Hemminki K; Försti A; Bandapalli OR
Front Endocrinol (Lausanne); 2021; 12():600682. PubMed ID: 33692755
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
